What is PCI Pharma Services?
PCI Pharma Services is a comprehensive, integrated provider catering to the global healthcare industry. Its extensive suite of services encompasses analytical services, formulation development, clinical trial supply management, commercial manufacturing and packaging, Qualified Person (QP) services, supply chain optimization, and secure storage and distribution. Headquartered in Philadelphia, Pennsylvania, with a strategic presence across the United States and Europe, PCI Pharma Services plays a critical role in bringing life-saving therapies from development to market.
How much funding has PCI Pharma Services raised?
PCI Pharma Services has raised a total of $920M across 1 funding round:
Debt
$920M
Debt (2020): $920M with participation from Jefferies
Key Investors in PCI Pharma Services
Jefferies
Jefferies is a global investment banking and capital markets firm providing a wide range of financial advisory, capital raising, and investment services. Their involvement suggests a strategic financial backing aimed at supporting PCI Pharma Services' growth and operational scaling.
What's next for PCI Pharma Services?
The substantial enterprise-level backing and recent strategic investment signal a period of aggressive expansion and service enhancement for PCI Pharma Services. This capital will likely fuel advancements in their manufacturing capabilities, R&D for novel drug delivery systems, and the broadening of their global footprint. The company is well-positioned to capitalize on increasing demand for integrated pharmaceutical services, particularly in complex areas like biologics and specialized therapeutics, solidifying its status as a key partner in pharmaceutical development and commercialization.
See full PCI Pharma Services company page
